Synthace Ltd
Classification
Private
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
About
About
Synthace Ltd is a biotechnology company that is revolutionizing the way life science research and development is conducted. Founded in 2011, the company has established itself as a leading provider of software solutions and automation tools that enable scientists to design, optimize, and execute complex experiments more efficiently and with unprecedented precision. Synthace's innovative platform accelerates scientific discovery and streamlines the development of novel therapies, making a profound impact on the biotech and pharmaceutical industries. Product/Service Line Breakdown: Antha Platform: Laboratory Automation: Synthace's Antha platform serves as an integrated laboratory automation system, enabling scientists to automate and standardize complex experimental workflows. This reduces manual errors, increases efficiency, and enhances data reproducibility. Experiment Design and Optimization: The Antha platform allows researchers to design, simulate, and optimize experiments in silico, ensuring the most efficient use of resources and faster results in the laboratory. Data Integration and Analysis: Synthace's software tools facilitate data integration from various sources, enabling seamless collaboration and analysis across multidisciplinary teams. Bioprocessing Solutions: Cell Engineering: Synthace offers tools for precise cell engineering, including gene editing and pathway optimization, supporting the development of cell therapies and biologics. Fermentation Optimization: The company's solutions assist in optimizing fermentation processes, enhancing the production of biopharmaceuticals and bio-based products. Drug Discovery and Development: Virtual Screening: Synthace's platform includes virtual screening capabilities, helping researchers identify potential drug candidates and optimize molecular structures before proceeding to physical experiments. High-Throughput Screening: The company's automation tools enable high-throughput screening of compounds, expediting drug discovery efforts. Synthetic Biology: Genetic Circuit Design: Synthace provides tools for designing genetic circuits and synthetic biological systems, facilitating the engineering of organisms for various applications, such as biomanufacturing and bioenergy. Collaboration and Knowledge Sharing: Teamwork and Collaboration: Synthace's platform fosters seamless collaboration among researchers, allowing them to work together on shared experiments and data. Knowledge Management: The platform facilitates knowledge sharing and preserves institutional expertise, ensuring continuity and avoiding duplication of research efforts. Training and Support: Onboarding and Training: Synthace offers onboarding and training services to assist organizations in adopting the Antha platform effectively. Customer Support: The company provides ongoing customer support, ensuring a smooth and efficient user experience.
Keywords
Keywords
Classified
Private